IRIS
TORINO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.273
AS - Asia 3.688
EU - Europa 3.195
SA - Sud America 515
Continente sconosciuto - Info sul continente non disponibili 297
AF - Africa 75
OC - Oceania 30
Totale 32.073
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.057
SG - Singapore 1.524
IT - Italia 1.075
CN - Cina 711
BR - Brasile 414
HK - Hong Kong 369
RU - Federazione Russa 359
VN - Vietnam 350
DE - Germania 326
UA - Ucraina 306
IE - Irlanda 226
FI - Finlandia 189
FR - Francia 185
GB - Regno Unito 163
BD - Bangladesh 151
CA - Canada 136
JP - Giappone 132
NL - Olanda 94
KR - Corea 80
IN - India 71
ID - Indonesia 63
SE - Svezia 55
TR - Turchia 53
AR - Argentina 33
MX - Messico 33
PL - Polonia 32
AT - Austria 28
BE - Belgio 28
AU - Australia 27
CZ - Repubblica Ceca 26
TW - Taiwan 24
EC - Ecuador 22
IR - Iran 19
MY - Malesia 19
ES - Italia 18
CO - Colombia 17
ZA - Sudafrica 17
PH - Filippine 15
EG - Egitto 14
AL - Albania 13
GR - Grecia 13
IQ - Iraq 13
JM - Giamaica 13
NP - Nepal 13
PK - Pakistan 13
SA - Arabia Saudita 13
CH - Svizzera 11
CL - Cile 11
TH - Thailandia 11
VE - Venezuela 10
CR - Costa Rica 9
MA - Marocco 9
TN - Tunisia 9
DZ - Algeria 8
LT - Lituania 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
DK - Danimarca 6
EU - Europa 6
GT - Guatemala 6
PT - Portogallo 6
UZ - Uzbekistan 6
NO - Norvegia 5
PY - Paraguay 5
RS - Serbia 5
AZ - Azerbaigian 4
LB - Libano 4
NG - Nigeria 4
HN - Honduras 3
JO - Giordania 3
KE - Kenya 3
NI - Nicaragua 3
OM - Oman 3
PE - Perù 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BW - Botswana 2
CI - Costa d'Avorio 2
EE - Estonia 2
ET - Etiopia 2
IL - Israele 2
KG - Kirghizistan 2
MD - Moldavia 2
MK - Macedonia 2
MN - Mongolia 2
MO - Macao, regione amministrativa speciale della Cina 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
Totale 31.769
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.943
Houston 5.083
Wilmington 5.045
Singapore 940
Ashburn 690
Fairfield 622
Chandler 592
San Jose 524
Ann Arbor 448
Council Bluffs 434
Hong Kong 352
Beijing 324
Rome 278
Seattle 266
Jacksonville 250
Dublin 215
Cambridge 206
New York 191
The Dalles 182
Medford 153
Santa Clara 140
Los Angeles 117
Helsinki 115
Dearborn 102
Tokyo 95
Hanoi 87
Buffalo 86
Milan 85
Dallas 76
Lawrence 75
Ho Chi Minh City 72
Boardman 69
Chicago 63
Lauterbourg 62
Moscow 62
Redwood City 55
Phoenix 46
Jakarta 44
Munich 43
San Diego 42
São Paulo 40
Dong Ket 39
Denver 38
London 31
Toronto 31
North Bergen 30
Menlo Park 29
Montreal 28
Mülheim 27
Nuremberg 27
Brooklyn 25
Columbus 25
Salt Lake City 25
Miami 23
Nanjing 22
Naples 22
Warsaw 22
Brno 21
Brussels 21
Verona 21
Amsterdam 20
Springfield 19
Sanayi 18
Norwalk 17
Orem 17
Redondo Beach 17
Escondido 16
Florence 16
Lachine 16
New Kensington 16
University Park 16
Washington 16
Turin 15
Atlanta 14
Guangzhou 14
Taipei 14
Brasília 13
Frankfurt am Main 13
Istanbul 13
Poplar 13
Vienna 13
Falls Church 12
Lappeenranta 12
Las Vegas 12
Palermo 12
Philadelphia 12
Rio de Janeiro 12
Shanghai 12
Stockholm 12
Tampa 12
Zhengzhou 12
Boston 11
Johannesburg 11
Mountain View 11
Belo Horizonte 10
Charlotte 10
Chennai 10
Da Nang 10
Hefei 10
Kathmandu 10
Totale 25.360
Salva come PNG Salva come JPEG
Nome #
Cultural adaptation and linguistic validation of the Family Decision Making Self Efficacy Scale (FDMSES) 666
La mutualità nel caregiving: una revisione della letteratura 625
Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses. 623
Prometheus: A Project for the Dissemination of Knowledge within the Oncology Network of Piedmont and Aosta Valley. 546
A novel method for monitoring response to chemotherapy based on the detection of circulating cancer cells: a case report 544
Thyroid dysfunction as an unintended side effect of anticancer drugs. 512
Focus on Fotemustine 510
A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer. 510
Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy. 506
Medullary thyroid cancer: a promising model for targeted therapy. 504
Unusual sites of metastatic malignancy: case 1. Cardiac metastasis in hepatocellular carcinoma. 503
Circulating tumor cells in colorectal cancer patients 501
Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G2/M cell accumulation induced by temozolomide in malignant glioma cells 496
Endocrine side effects induced by immune checkpoint inhibitors. 488
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors 488
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies 478
Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer. 473
A rare case of juvenile hypertension: Coexistence of type 2 multiple endocrine neoplasia -related bilateral pheochromocytoma and reninoma in a young patient with ACE gene polymorphism 473
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer 467
Efficacy and mucosal toxicity of concomitant chemo-radiotherapy in patients with locally-advanced squamous cell carcinoma of the head-and-neck in the light of a novel mathematical model 464
Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives. 463
Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not). 463
The contribution of targeted therapy to the neoadjuvant chemoradiation of rectal cancer. 463
Prognostic and Predictive Significance of Surrogate Biomarkers of Angiogenesis. 462
Endocrinological side-effects of immune checkpoint inhibitors 461
Hypophysitis induced by monoclonal antibodies to cytotoxic T lymphocyte antigen 4: challenges from a new cause of a rare disease. 456
Endocrine side effects induced by immune checkpoint inhibitors. 455
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer. 453
Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy 448
Thyroid Function Abnormalities in Patients Receiving Anticancer Agents. 447
Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer. 442
Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience 441
"Occult" ovarian Leydig cell tumor: when laboratory tells more than imaging. 441
Targeted therapy of breast cancer. 440
Is hypothyroidism a clinically relevant toxicity of tyrosine kinase inhibitors? 440
Mouse models of medullary thyroid cancer and developing new targeted therapies 439
Therapy of breast cancer with molecular targeting agents. 435
Testicular and inguinal lymph node metastases of medullary thyroid cancer: a case report and review of the literature. 432
Skin acrometastases in squamous cell carcinoma of the tongue. 427
Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancer. 422
Therapeutic agents that inhibit angiogenesis. 421
Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro 420
Clinical utility of lanreotide autogel® in gastroenteropancreatic neuroendocrine tumors 415
Genetic and molecular pathophysiology of medullary thyroid cancer. 412
Is tailored therapy feasible in oncology? 411
Predicting ovarian activity in women affected by early breast cancer: Ameta-analysis-based nomogram 410
Recognizing menopause in women with amenorrhea induced by cytotoxic chemotherapy for endocrine-responsive early breast cancer. 403
Barriers in the management of cancerrelated pain and strategies to overcome them: findings of a qualitative research involving physicians and nurses in Italy 401
Tailored therapy of colorectal cancer: results, challenges and future directions. 400
Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all? 390
Cultural adaptation and linguistic validation of the Family Decision Making Self Efficacy Scale (FDMSES). 389
Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain? 387
Combination of antiangiogenic therapy with other anticancer treatment. 379
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer 378
Failure of a cetuximab/bevacizumab schedule in a patient with metastatic desmoplastic small round-cell tumour refractory to chemotherapy. 369
Molecular targeted therapy of medullary thyroid carcinoma 344
Gut microbiota and cancer: From pathogenesis to therapy 252
Lactobacillus rhamnosus GG: An overview to explore the rationale of its use in cancer 249
Role of Mitotane in Adrenocortical Carcinoma - Review and State of the art 247
Validity and Reliability of the Self-Care of Chronic Illness Inventory and Self-Care Self-Efficacy Scale in Patients Living With Cancer 188
Drug-induced neoantigen: a new horizon in cancer immunotherapy? 185
Abscopal effect and drug-induced xenogenization: a strategic alliance in cancer treatment? 185
Insulin Resistance as a Risk Factor for Cutaneous Melanoma. A Case Control Study and Risk-Assessment Nomograms 182
Cancer management during COVID-19 pandemic: is immune checkpoint inhibitors-based immunotherapy harmful or beneficial? 161
Apoptosis as a Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer 161
Development and content validity of the self-care of oral anticancer agents index 155
Case Report: Ipilimumab-Induced Panhypophysitis: An Infrequent Occurrence and Literature Review 151
Urine LOX-1 and volatilome as promising tools towards the early detection of renal cancer 151
Extracellular volume measured by whole body CT scans predicts chronic cardiotoxicity in breast cancer patients treated with neoadjuvant therapies based on anthracyclines: a retrospective study 150
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events? 145
Development and Content Validity of the Self-Care of Oral Anticancer Agents Index (SCOAAI) 143
Psychometric Properties of the Self Care Oral Anticancer Agents Index (SCOAAI) 143
Self-care behaviors in patients with cancer treated with oral anticancer agents: a systematic review 142
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series 139
Activity of ALK inhibitors in renal cancer with ALK alterations: a systematic review 139
A scoping review on the "burned out" or "burnt out" testicular cancer: When a rare phenomenon deserves more attention 138
A systematic review of self-care behaviours among patients with cancer who take oral anticancer agents 134
Indirect basal metabolism estimation in tailoring recombinant human TSH administration in patients affected by differentiated thyroid cancer: A hypothesis-generating study 133
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? 128
Case report: Metastatic melanoma derived from a somatic-type malignant transformation of a mediastinal teratoma treated with immune checkpoint inhibitors 125
La Terza Missione dell'Università: formazione e salute 125
Describing self-care behaviours in cancer patients taking oral anticancer agents 122
Investigating Physical, Social, Emotional, and Health Frailties of Cancer Survivors after Cancer Treatment: The Urgent Call for Tailored Multidisciplinary Survivorship Plans in Italy 116
AMBRA1 and SQSTM1 expression pattern in prostate cancer 115
Self-care behaviours in older adults treated with oral anticancer agents: A qualitative descriptive study 108
Predictors of self-care in patients with cancer treated with oral anticancer agents: A systematic review 106
Androgen Deprivation Freezes Hormone-Sensitive Prostate Cancer Cells in a Reversible, Genetically Unstable Quasi-Apoptotic State, Bursting into Full Apoptosis upon Poly(ADP-ribose) Polymerase Inhibition 103
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 103
Bone Metabolism Effects of Medical Therapy in Advanced Renal Cell Carcinoma 102
Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation 101
Metabolic reprogramming of castration-resistant prostate cancer cells as a response to chemotherapy 100
Core Outcomes of Self-Care Behaviours in Patients with Breast Cancer Treated with Oral Anticancer Agents: A Systematic Review 98
Unemployment Status Subsequent to Cancer Diagnosis and Therapies: A Systematic Review and Meta-Analysis 98
CN29 Short term effects of self-care behaviours on quality of life for patients on oral anticancer agents 97
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review 95
Caregivers’ contribution to self-care for patients treated with oral anticancer agents: A qualitative descriptive study 94
Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives 93
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer 89
Leveraging knowledge for explainable AI in personalized cancer treatment: challenges and future directions 86
Asymptomatic Hypocalcemia Related to Denosumab Administration in Bone-Metastatic Patient Affected by Colorectal Cancer: A Case Report 82
Totale 31.595
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.827
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022763 0 0 0 50 35 71 47 43 53 109 64 291
2022/20231.438 137 154 130 158 107 267 82 93 116 23 125 46
2023/2024621 85 34 32 27 48 106 37 32 22 17 16 165
2024/20252.583 87 474 200 135 76 178 222 176 222 344 258 211
2025/20265.174 425 208 474 337 512 201 784 618 545 495 367 208
2026/20271.688 347 257 851 233 0 0 0 0 0 0 0 0
Totale 32.073